Skip to main content

Drugs

Ausgabe 5/2022

Inhalt (10 Artikel)

Leading Article

Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?

Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes

Open Access Review Article

From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome

Thomas J. P. Mangnus, Krishna D. Bharwani, Maaike Dirckx, Frank J. P. M. Huygen

Review Article

Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria

George G. Zhanel, Marianna Pozdirca, Alyssa R. Golden, Courtney K. Lawrence, Sheryl Zelenitsky, Liam Berry, Frank Schweizer, Denice Bay, Heather Adam, Michael A. Zhanel, Philippe Lagacé-Wiens, Andrew Walkty, Neal Irfan, Kurt Naber, Joseph P. Lynch III, James A. Karlowsky

Review Article

Contemporary Management of Dyslipidemia

Richard A. Ferraro, Thorsten Leucker, Seth S. Martin, Maciej Banach, Steven R. Jones, Peter P. Toth

Adis Drug Evaluation

Aumolertinib: A Review in Non-Small Cell Lung Cancer

Matt Shirley, Susan J. Keam

Open Access AdisInsight Report

Nirmatrelvir Plus Ritonavir: First Approval

Yvette N. Lamb

AdisInsight Report

Sugemalimab: First Approval

Sohita Dhillon, Sean Duggan

Open Access AdisInsight Report

Daridorexant: First Approval

Anthony Markham

Open Access Correction

Correction to: Abrocitinib: First Approval

Emma D. Deeks, Sean Duggan

Open Access Correction

Correction to: Efgartigimod: First Approval

Young-A Heo

Aktuelle Ausgaben